<DOC>
	<DOCNO>NCT01213667</DOCNO>
	<brief_summary>To assess genetic feature intraocular cytokine profile non-responders anti-VEGF treatment exudative age-related macular degeneration . Also assess necessity frequency pro nate medical re-treatment .</brief_summary>
	<brief_title>Genetics Non-response Anti-VEGF Treatment Exudative AMD</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>active subfoveal CNV relate exudative agerelated macular degeneration ( subforms ) age &gt; 60 year visual acuity &gt; 20/400 previous treatment AMD previous AMD therapy CNV type ( myopic , parapapillary ) contraindication ranibizumab treatment prior study participation AMD pregnancy / premenopausal woman</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>